Skip to main content

Table 2 Characteristics of five-year survivors without disease recurrence

From: Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma

Age/gender

CA19-9 (U/mL)

Tumor location

Tumor size (mm)

UICC stage

TNM-N

Number of lymph node metastasis

Surgery

R

Outcome (month)

Recurrence

71/F

2

Pb

16

IA

0

0

DP

0

68/A

None

76/F

65

Ph

30

IIB

1

2

PD

0

69/D

None

72/M

597

Pt

40

IIB

1

2

DP

1

73/D

Dissemination

57/M

611

Ph

42

IIB

0

0

PD with PV

0

74/A

None

73/F

3221

Pbt

32

IIB

1

2

DP

0

78/A

None

76/M

21

Ph

20

IIA

0

0

PD

0

79/D

None

62/M

103

Ph

40

IIB

1

2

PD

0

85/D

Lymph node

61/M

29

Ph

12

IIA

0

0

PD

1

86/A

None

46/M

31

Ph

40

IIA

0

0

PD

0

89/D

Liver/local

68/F

2381

Ph

55

IIA

0

0

PD

0

92/A

None

73/M

39

Pb

38

IIB

1

1

DP

0

100/A

None

60/F

34

Ph

50

IIB

1

2

PD

0

108/A

None

70/M

29

Ph

32

IB

0

0

PD

0

111/A

None

57/M

20

Ph

30

IIB

1

2

PD with PV

1

122/D

Lung/skin

56/M

4.1

Ph

20

IIA

0

0

PD

0

129/D

None

57/M

30

Pb

30

IB

0

0

DP

0

144/A

None

57/M

7

Pb

35

IIA

0

0

DP

0

145/A

None

70/M

2

Ph

15

IIB

1

1

PD

1

170/A

None

  1. A, alive; D, dead; DP, distal pancreatectomy; Pb, body of the pancreas; Pbt, body and tail of the pancreas; PD, pancreaticoduodenectomy; Ph, head of the pancreas; Pt, tail of the pancreas; PV, portal vein resection; R, resection status.